• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Virol J . Respiratory viral infections in hospitalized adults: a comparative clinico-laboratory study of RSV, HMPV, and influenza

tetano

Editor, Senior Moderator
Virol J


. 2025 Aug 28;22(1):294.
doi: 10.1186/s12985-025-02924-2. Respiratory viral infections in hospitalized adults: a comparative clinico-laboratory study of RSV, HMPV, and influenza

Santhosha Devadiga[SUP] #[/SUP][SUP] 1 [/SUP], Prasad Varamballi[SUP] 1 [/SUP], Ujwal Shetty[SUP] 1 [/SUP], Chiranjay Mukhopadhyay[SUP] 1 [/SUP], Anup Jayaram[SUP] 2 [/SUP]



Affiliations
Abstract

Background: Respiratory viral infections, including Human Metapneumovirus (HMPV), Influenza (Flu), and human Respiratory Syncytial Virus (hRSV), are major global health concerns. While their impact on vulnerable groups is known, their characteristics in healthy adults (18-65 years) are less clear. This study aimed to determine the incidence and clinical-laboratory features of RSV and HMPV in this population and compared them with those of Influenza A(H1N1) and influenza A(H3N2) for improved epidemiological and diagnostic understanding.
Methodology: A retrospective analysis was conducted on data from an Acute Febrile Illness surveillance (2016-2018) in Manipal, India. The study included 96 HMPV, 68 hRSV, 75 Influenza A(H1N1), and 76 Influenza A(H3N2) positive hospitalized adults with fever (≥ 38 °C) and respiratory illness confirmed by RT‒PCR. Clinical and laboratory data collected within the first 8 days of illness were statistically analyzed.
Results: The annual incidence rates of hRSV (0.33%-1.59%) and HMPV (0.14%-1.79%) varied. Coryza was common, but cough was most frequent in HMPV (97.9%). HMPV also resulted in increased rates of shortness of breath and chest pain. Leucopenia was most common in Influenza A(H1N1) patients, and thrombocytopenia was most common in hRSV patients. Significantly elevated leukocyte and platelet counts were observed in HMPV patients. Liver enzyme abnormalities are relatively common in hRSV and Influenza A(H1N1) patients. Symptom progression and laboratory trends revealed distinct patterns across the viruses.
Conclusion: Despite overlapping initial symptoms, HMPV, hRSV, and influenza resulted in different clinical and laboratory profiles in adults. HMPV was associated with more prominent lower respiratory symptoms and a stronger inflammatory response. These distinctions can aid in the clinical differentiation and management of these common respiratory viruses in adults, highlighting the importance of timely diagnosis for improved patient care and public health strategies.

Keywords: Clinical; Comparative study; Human metapneumovirus; Human respiratory syncytial virus; Influenza; Laboratory.

 
Back
Top Bottom